International Journal of Legal Medicine · Nov 18, 2026

Revisiting sex chromosome dosage variation as a biomarker for forensic age estimation

By Chen A, Yang F, Liu Y et al.

Accumulating evidence suggests that age-related sex chromosome alterations may be relevant to biological aging. However, their utility for forensic age estimation remains uncertain. This study evaluated the potential of sex chromosome dosage variation for age prediction, with further assessment of quantification methods and analytical strategies to improve predictive performance. Sex chromosome dosage was quantified by qPCR in blood samples from 258 females and 200 males, targeting X- and Y-specific AMEL sequences and the autosomal reference gene RPP30. Additional ddPCR measurements were obtained from 361 individuals (206 females and 155 males), including 285 individuals analyzed by both methods. Linear regression models were constructed using chromosome dosage metrics and evaluated by five-fold cross-validation. Although ddPCR yielded dosage estimates close to the expected theoretical values, it did not demonstrate better age prediction performance than qPCR. ddPCR-derived Y chromosome dosage showed a weak but statistically significant negative correlation with age. Neither chromosome loss metrics nor alternative normalization strategies improved predictive performance. These findings suggested that improved quantification and analytical strategies did not overcome the limited age-predictive value of sex chromosome dosage, highlighting the distinction between biological relevance and forensic utility when evaluating candidate molecular biomarkers.

doi.org/10.1007/s00414-026-04073-9PubMed 43049810Biomarkers

AgingResearch.News